financetom
Business
financetom
/
Business
/
China criticises US tightening of chip export rules
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China criticises US tightening of chip export rules
Mar 31, 2024 8:47 PM

BEIJING (Reuters) - China has criticised the tightening of U.S. rules on semiconductor exports, saying they have created more hurdles to trade and more uncertainty in the chip industry.

The Biden administration last week revised rules aimed at making it harder for China to access U.S. artificial intelligence chips and chipmaking tools, part of a larger effort to hobble Beijing's chipmaking industry over national security concerns.

"The U.S. has broadened the concept of national security, arbitrarily revised the rules, and tightened control measures. That has not only set up more obstacles and imposed a heavier compliance burden on Chinese and American companies who want to work together economically and in trade normally but has also created huge uncertainty for the global semiconductor industry," a Commerce Ministry spokesperson said, according to a statement.

The spokesperson, responding to a reporter's question, said the move by the U.S. "seriously affects mutually beneficial cooperation between Chinese and foreign enterprises and harms their legitimate rights and interests. China firmly opposes this."

The U.S. imposed rules last October barring exports and companies like Nvidia and AMD have been affected by the spat.

"China is ready to work with all parties to strengthen mutually beneficial cooperation and promote the security and stability of the global semiconductor industry and supply chain," the spokesperson said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA requests removal of suicide warnings from weight-loss drugs
US FDA requests removal of suicide warnings from weight-loss drugs
Mar 11, 2026
Jan 13 (Reuters) - The U.S. Food ‌and ​Drug Administration on ‍Tuesday requested ⁠companies ⁠to ‌remove ​warnings related to ⁠the potential ‍risk ​of suicidal ideation and ‍behavior from the labeling of ​popular ‍weight-loss drugs of ​the GLP-1 class. ...
--Street Color: Meta Platforms, EssilorLuxottica in Potential Talks to Double Ray-Ban Glasses Output, Bloomberg Reports
--Street Color: Meta Platforms, EssilorLuxottica in Potential Talks to Double Ray-Ban Glasses Output, Bloomberg Reports
Mar 11, 2026
09:54 AM EST, 01/13/2026 (MT Newswires) -- Price: 635.04, Change: -6.93, Percent Change: -1.08 ...
Rithm Capital Launches Preferred Stock Offering
Rithm Capital Launches Preferred Stock Offering
Mar 11, 2026
09:52 AM EST, 01/13/2026 (MT Newswires) -- Rithm Capital ( RITM ) said Tuesday that it has launched an underwritten public offering of series F fixed-rate reset cumulative redeemable preferred stock based on market conditions. The company said it intends to list the preferred stock on the New York Stock Exchange under the symbol RITM PR F, and that terms...
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
Mar 11, 2026
HAIFA, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, today announced that it has been granted two new U.S. patents that further expand and strengthen its global intellectual property portfolio supporting its proprietary Mitochondrial Augmentation Therapy (MAT) platform. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved